These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

844 related articles for article (PubMed ID: 31736194)

  • 1. Insights on the current status and advancement of diabetes mellitus type 2 and to avert complications: An overview.
    Chung IM; Rajakumar G; Subramanian U; Venkidasamy B; Khanna VG; Thiruvengadam M
    Biotechnol Appl Biochem; 2020 Nov; 67(6):920-928. PubMed ID: 31736194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and characterization of a novel rat model of type 2 diabetes mellitus: the UC Davis type 2 diabetes mellitus UCD-T2DM rat.
    Cummings BP; Digitale EK; Stanhope KL; Graham JL; Baskin DG; Reed BJ; Sweet IR; Griffen SC; Havel PJ
    Am J Physiol Regul Integr Comp Physiol; 2008 Dec; 295(6):R1782-93. PubMed ID: 18832086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology of type 2 diabetes: targeting islet cell dysfunction.
    Spellman CW
    J Am Osteopath Assoc; 2010 Mar; 110(3 Suppl 2):S2-7. PubMed ID: 20382838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can thiazolidinediones delay disease progression in type 2 diabetes?
    Leiter LA
    Curr Med Res Opin; 2006 Jun; 22(6):1193-201. PubMed ID: 16846552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Boolean network modeling of β-cell apoptosis and insulin resistance in type 2 diabetes mellitus.
    Dutta P; Ma L; Ali Y; Sloot PMA; Zheng J
    BMC Syst Biol; 2019 Apr; 13(Suppl 2):36. PubMed ID: 30953496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 2 diabetes mellitus.
    DeFronzo RA; Ferrannini E; Groop L; Henry RR; Herman WH; Holst JJ; Hu FB; Kahn CR; Raz I; Shulman GI; Simonson DC; Testa MA; Weiss R
    Nat Rev Dis Primers; 2015 Jul; 1():15019. PubMed ID: 27189025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-cell failure in type 2 diabetes mellitus.
    Lencioni C; Lupi R; Del Prato S
    Curr Diab Rep; 2008 Jun; 8(3):179-84. PubMed ID: 18625113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulsatile insulin secretion, impaired glucose tolerance and type 2 diabetes.
    Satin LS; Butler PC; Ha J; Sherman AS
    Mol Aspects Med; 2015 Apr; 42():61-77. PubMed ID: 25637831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes as a risk factor to cancer: functional role of fermented papaya preparation as phytonutraceutical adjunct in the treatment of diabetes and cancer.
    Aruoma OI; Somanah J; Bourdon E; Rondeau P; Bahorun T
    Mutat Res; 2014 Oct; 768():60-8. PubMed ID: 24769427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency of Urokinase Plasminogen Activator May Impair β Cells Regeneration and Insulin Secretion in Type 2 Diabetes Mellitus.
    Wu CZ; Ou SH; Chang LC; Lin YF; Pei D; Chen JS
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31756973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing the Concept of Type 2 Diabetes: Beta Cell Workload Hypothesis Revisited.
    Saisho Y
    Endocr Metab Immune Disord Drug Targets; 2019; 19(2):121-127. PubMed ID: 30173655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of pancreatic beta-cells: is it feasible?
    Bonora E
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the treatment of type 2 diabetes mellitus.
    Israili ZH
    Am J Ther; 2011; 18(2):117-52. PubMed ID: 19834322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A shared comparison of diabetes mellitus and neurodegenerative disorders.
    Morsi M; Maher A; Aboelmagd O; Johar D; Bernstein L
    J Cell Biochem; 2018 Feb; 119(2):1249-1256. PubMed ID: 28681964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current views on type 2 diabetes.
    Lin Y; Sun Z
    J Endocrinol; 2010 Jan; 204(1):1-11. PubMed ID: 19770178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic Fat is not significantly correlated with β-cell Dysfunction in Patients with new-onset Type 2 Diabetes Mellitus using quantitative Computed Tomography.
    Li YX; Sang YQ; Sun Y; Liu XK; Geng HF; Zha M; Wang B; Teng F; Sun HJ; Wang Y; Qiu QQ; Zang X; Wang Y; Wu TT; Jones PM; Liang J; Xu W
    Int J Med Sci; 2020; 17(12):1673-1682. PubMed ID: 32714070
    [No Abstract]   [Full Text] [Related]  

  • 17. Defects in insulin secretion and action in the pathogenesis of type 2 diabetes mellitus.
    Tripathy D; Chavez AO
    Curr Diab Rep; 2010 Jun; 10(3):184-91. PubMed ID: 20425581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of beta-cell dysfunction, ectopic fat accumulation and insulin resistance in the pathogenesis of type 2 diabetes mellitus.
    Gastaldelli A
    Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S60-5. PubMed ID: 21864753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic β cells: Gatekeepers of type 2 diabetes.
    Park YJ; Woo M
    J Cell Biol; 2019 Apr; 218(4):1094-1095. PubMed ID: 30696700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel approaches to drug discovery for the treatment of type 2 diabetes.
    Xu X; Wang G; Zhou T; Chen L; Chen J; Shen X
    Expert Opin Drug Discov; 2014 Sep; 9(9):1047-58. PubMed ID: 25054271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.